Company page
Chemocentryx Inc.
Chemocentryx Inc. (ticker: CCXI) is a public company based in America, with a market capitalization of approximately $573.99 million. The company focuses on developing innovative therapies for autoimmune diseases and cancer. Chemocentryx is dedicated to advancing its pipeline of drug candidates to address unmet medical needs.
- Ticker
- CCXI:NASDAQ
- Asset type
- Stock
- Market cap
- $574.0M
- Sector
- Finance
- Industry
- Financial Conglomerates
- Exchange
- NASDAQ
- Currency
- USD